Effects for Oral Mucositis Care During Chemoradiotherapy in Cancer Patients: Evaluation of the Bee Products
NCT ID: NCT05625841
Last Updated: 2022-11-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
135 participants
INTERVENTIONAL
2022-11-25
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Honey Products for Cancer Patients With Oral Mucositis: a Randomized Controlled Trial
NCT04382079
Microbiota and Symptom Distress in Head and Neck Cancer Patients Receiving Radiotherapy
NCT04843644
The Effect of Honey on Xerostomia and Oral Mucositis
NCT01465308
The Effectiveness of a Thyme and Honey Spray for Oral Toxicities
NCT04880148
Effectiveness of Thyme Honey in Management of Xerostomia in Post Radiation Cancer Patients
NCT05859711
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Questionnaire collection: oral mucositis grade, pain scale, fatigue scale, dry mouth, nutritional status and quality of life scale.
2. Wearing the smart bracelet: The smart bracelet will automatically detect heart rate variability, heartbeat, sleep and activity status.
3. Saliva sample collection: Test the concentration of IL-1, IL-6, IL-10 and TNF in saliva.
4. Stool and oral flora collection: Test stool and oral flora microbiota.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Honey
Each pack of 10 grams of honey after three meals a day.
Honey product
Bee products intervention from the first day of radiation to the end of radiation therapy duration 8-12 weeks.
Honey and propolis
Each pack contains 0.7ml of propolis + 9.3g of honey after three meals a day.
Honey product
Bee products intervention from the first day of radiation to the end of radiation therapy duration 8-12 weeks.
propolis
propolis
Usual care
General routine oral care.
Usual care
Usual care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Honey product
Bee products intervention from the first day of radiation to the end of radiation therapy duration 8-12 weeks.
propolis
propolis
Usual care
Usual care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. receive chemotherapy or radiotherapy.
3. conscious clear and willing to participate in the research.
4. can communicate in Mandarin or Taiwanese.
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taipei Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tsai-Wei Huang, PhD
Role: PRINCIPAL_INVESTIGATOR
Taipei Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taipei Medical University
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Tsai-Wei Huang, PhD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tsai-Wei Huang, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N2021100301
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.